Office of Clinical Research

Questions? Contact Us
Phone Number
Call 434.243.6303

The Office of Clinical Research (OCR) at the Cancer Center provides centralized support for the conduct of cancer clinical trials to all Cancer Center investigators. We support:

OCR Leadership

The OCR Leadership ensures the development of clinical trials and of the infrastructure needed to support the clinical research enterprise.


Dreicer, MD

Robert Dreicer, MD, MS, FACP, FASCO
Associate Director for Clinical Research

As the Cancer Center’s Associate Director for Clinical Research, Dr. Dreicer works on strengthening its clinical research enterprise by engaging Cancer Center clinicians and researchers in the development and implementation of clinical trials evaluating cutting-edge cancer therapies.


Dina Halme

Dina Gould Halme, PhD
Associate Director for Research Administration

As Associate Director for Research Administration, Dr. Halme manages all aspects of the Cancer Center research enterprise. Her responsibilities include fiscal and administrative management of the Office for Clinical Research.


Parchayi Dalal, MPH, CCRC

Parchayi Dalal, MPH, CCRC
Director, Office of Clinical Research

As the Director of the Cancer Center Office for Clinical Research (OCR), Parchayi leads and administers the centralized infrastructure of the OCR and provides overall accountability for the clinical, regulatory, and financial programs within the OCR. She also assists the Cancer Center Senior Leadership with the development, promotion and implementation of the Cancer Center strategic plan for clinical trials research and the development of research affiliations within UVA, with NCI, and with industry providing expansion of clinical trials opportunities for Cancer Center patients.


Emily Allred, PhD, CCRC
Program Manager-Solid Tumor Oncology, Office of Clinical Research

Claire McKinley, CCRP, PMP
Program Manager- Hematologic Malignancies, Office of Clinical Research


View the complete Office of Clinical Research organizational chart (PDF)